Panel Discussion: Healthcare Reform and its Impact on the Biopharmaceutical Industry

Novo Nordisk's Mike Mawby, Deloitte's Matthew Hudes and Engel & Novitt's John Engel discuss healthcare reform and the biopharm industry at Interphex 2010.